You are here

  • Home
  • Archive
  • Volume 99, Issue Suppl 2
  • PO-0934 Comparative Paediatric Acetaminophen Pharmacokinetics Between A Microdose And A Therapeutic Dose Using Accelerator Mass Spectrometry Bioanalysis

Article Text

Article menu
Pharmacology
PO-0934 Comparative Paediatric Acetaminophen Pharmacokinetics Between A Microdose And A Therapeutic Dose Using Accelerator Mass Spectrometry Bioanalysis
Free
  1. MA Turner1,
  2. BK Park2,
  3. NS French2,
  4. C Earnshaw2,
  5. A Schipani2,
  6. AM Selby3,
  7. L Byrne3,
  8. S Siner3,
  9. WHJ Vaes4,
  10. E van Duijn4,
  11. RAF de Ligt4,
  12. H Varendi5,
  13. J Lass5,
  14. G Grynkiewicz6,
  15. W Maruszak6,
  16. F Crawley7,
  17. RC Garner8
  1. 1Women’s and Children’s Health, University of Liverpool, Liverpool, UK
  2. 2Institute of Translational Medicine, University of Liverpool, Liverpool, UK
  3. 3PICU, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
  4. 4Zeist, TNO, Zeist, Netherlands
  5. 5Paediatrcis, University of Tartu, Tartu, Estonia
  6. 6PRI, Pharmaceutical Research Institute, Warsaw, Poland
  7. 7Ethics, Good Clinical Practice Alliance – Europe, Brussels, Belgium
  8. 8University of York, Hull York Medical School, York, UK

Abstract

Objectives We wished to compare acetaminophen (APAP) paediatric pharmacokinetics (PK) after a therapeutic dose and a microdose. We developed and validated a new approach using Accelerator Mass Spectrometry (AMS) bioanalysis in the 0–2 year old age group.

Methods [14C] APAP concentrations in small volume blood samples were measured after enteral or IV administration of a single [14C] APAP microtracer dose as a microdose or incorporated in a therapeutic dose (microtracer with similar PK to the unlabelled APAP).

Results Dose normalised PK parameters AUC0-t, CL and Vss were comparable between a microtracer incorporated in a therapeutic dose and microdose (dose difference approximately 1.5 million fold) when administered either IV or enterally.

View this table:
Abstract PO-0934 Table 1

Conclusions Micro dosing using AMS bioanalysis is demonstrated to be both possible and practical in the paediatric population. The developed methods may offer ethical, increased bioanalytical sensitivity and safety advantages over dosing regimens used in paediatric PK studies with therapeutic doses.

https://doi.org/10.1136/archdischild-2014-307384.1555

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.